Abstract
(Abstracted from Obstet Gynecol 2023;142:242–250) A few years ago, the ARRIVE trial (A Randomized Trail of Induction Versus Expectant Management) reported that elective induction of labor at 39 weeks of gestation in low-risk nulliparous patients decreased the risk of cesarean birth and of hypertensive disorders of pregnancy compared with expectant management. This presented a possible means to decrease the high rates of cesarean delivery among this patient group.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
